Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | pfw | Structure of PDE10-inhibitor complex | 3qpp | 74.05 | | 12. |
2 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | jy7 | Novel, potent, selective and brain penetrant phosphodiesterase 10A inhibitors | 6msc | 83.97 | | no data |
3 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 9g6 | Crystal structure of PDE10A catalytic domain complexed with LHB-6 | 5znl | 77.78 | | no data |
4 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 4xu | PDE10 complexed with 6-chloro-N-[(2,4-dimethylthiazol-5-yl)methyl]-5-methyl-2-[3-(2-quinolyl)propoxy]pyrimidin-4-amine | 5c2h | 81.66 | | 0.0082 |
5 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 2f4 | Crystal Structure of PDE10A with Novel Keto-Benzimidazole Inhibitor | 4muw | 84.44 | | 9.7 |
6 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 0t7 | Potent and Selective Phosphodiesterase 10A Inhibitors | 4fcb | 80.36 | | 2.9 |
7 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 227 | Crystal structure of the catalytic domain of rat phosphodiesterase 10A | 2o8h | 60.5 | | 25. |
8 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | pfh | Crystal structure of the catalytic domain of rat phosphodiesterase 10A | 2ovv | 71.33 | | 12. |
9 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | ev1 | Human PDE-papaverine complex obtained by ligand soaking of cross- linked protein crystals | 2wey | 81.28 | | 76. |
10 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | pf6 | Discovery of novel inhibitors of PDE10A | 3hqy | 82.93 | | 11.5 |
11 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | pfr | Structure of PDE10-inhibitor complex | 3qpo | 70.84 | | 247. |
12 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 540 | Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitors | 3sn7 | 83.92 | | 0.7 |
13 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 546 | Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitors | 3sni | 82.14 | | 11. |
14 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | c1l | Discovery of orally active pyrazoloquinoline as a potent PDE10 inhibitor for the management of schizophrenia | 3ui7 | 79.87 | | 1. |
15 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | x4c | Crystal structure of PDE10A in complex with a benzimidazole inhibitor | 3ws8 | 77.36 | | 210. |
16 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | lkf | Discovery of a potent, selective and orally active PDE10A inhibitor for the treatment of schizophrenia | 4bbx | 78.48 | | no data |
17 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 0jq | PDE10a Crystal Structure Complexed with Novel Inhibitor | 4ddl | 66.58 | | 4.9 |
18 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 0t6 | Potent and Selective Phosphodiesterase 10A Inhibitors | 4fcd | 80.94 | | 0.28 |
19 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 15h | Crystal Structure of PDE10A with a biaryl ether inhibitor (1-(1-(3-(4-(benzo[d]thiazol-2-ylamino)phenoxy)pyrazin-2-yl)piperidin-4-yl)ethanol) | 4hf4 | 83.81 | | 2.4 |
20 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 2f5 | Crystal Structure of PDE10A with Novel Keto-Benzimidazole Inhibitor | 4mvh | 83.82 | | 4.5 |
21 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 2w1 | Crystal Structure of PDE10A with 1H-benzimidazol-2-yl(4-((3-(tetrahydro-2H-pyran-4-yl)-2-pyridinyl)oxy)phenyl)methanone | 4phw | 84.63 | | 0.1 |
22 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 4lp | Crystal structure of the catalytic domain of PDE10A complexed with highly potent and brain-penetrant PDE10A Inhibitor with 2-oxindole scaffold | 5axq | 71.94 | | 0.08 |
23 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 6dw | Crystal structure of the catalytic domain of human PDE10A complexed with 1-(cyclopropylmethyl)-5-(2-(2,3-dihydro-1H-imidazo[1,2-a]benzimidazol-1-yl)ethoxy)-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one | 5b4l | 78.56 | | 0.76 |
24 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 4xy | PDE10 complexed with 6-chloro-2-cyclopropyl-5-methyl-N-propyl-pyrimidin-4-amine | 5c29 | 86.03 | | 880. |
25 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 4y2 | PDE10 complexed with 6-chloro-2-cyclopropyl-N-[(2,4-dimethylthiazol-5-yl)methyl]-5-methyl-pyrimidin-4-amine | 5c2a | 85.48 | | 4.8 |
26 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 5ay | PDE10 complexed with N-[(1-methylpyrazol-4-yl)methyl]-5-[[(1S,2S)-2-(2-pyridyl)cyclopropyl]methoxy]pyrazolo[1,5-a]pyrimidin-7-amine | 5dh5 | 87.5 | | 0.23 |
27 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 5m6 | human PDE10A in complex with 1-(4-Chloro-phenyl)-3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxylic acid (tetrahydro-furan-2-ylmethyl)-amide at 2.2A | 5ede | 73.32 | | no data |
28 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 6rc | PDE10a with imidazopyrazine inhibitor | 5k9r | 77.08 | | no data |
29 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 8q7 | Crystal structure of human PDE10A in complex with inhibitor 16d | 5uwf | 81.97 | | 59. |
30 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 8g3 | Crystal structure of PDE10A in complex with 2-methyl-5-[2-([1,2,4]triazolo[1,5-a]pyrimidin-2-yl)et hyl]pyrazolo[1,5-a]pyrimidin-7-ol | 5xui | 82.66 | | no data |
31 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 5m9 | human PDE10A, 6-Chloro-5,8-dimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-2H-[1,2,4]triazol-3-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyridine, 2.20A, H3, Rfree=23.5% | 5edi | 84.1 | | 0.3 |
32 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 5mf | human PDE10A, 8-ethyl-5-methyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine, 2.03A, H3, Rfree=22.7% | 5edh | 84.16 | | no data |
33 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 6dt | Crystal structure of the catalytic domain of human PDE10A complexed with N-(4-((5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy)phenyl)-1H-benzimidazol-2-amine | 5b4k | 85.13 | | 0.46 |
34 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 490 | Crystal structure of PDE10A in complex with ASP9436 | 4xy2 | 78.38 | | 8. |
35 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 15j | Crystal Structure of PDE10A with a biaryl ether inhibitor ((1-(3-(4-((1H-benzo[d]imidazol-2-yl)amino)phenoxy)pyridin-2-yl)piperidin-4-yl)methanol) | 4heu | 90.53 | | 0.097 |
36 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | f03 | Identification and structural characterization of PDE10 fragment inhibitors | 4ajf | 83.68 | | no data |
37 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | 4hn | PDE10A in complex with the inhibitor AZ5 | 4ael | 84.09 | | 12. |
38 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | pfk | Structure of PDE10-inhibitor complex | 3qpn | 81.21 | | 17. |
39 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | pf9 | Discovery of novel inhibitors of PDE10A | 3hr1 | 86.36 | | 0.37 |
40 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | axc | Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors, part 2, Lead-optimisation. | 2y0j | 75.66 | | 12. |
41 | PDE10 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | | pfj | Crystal structure of the catalytic domain of rat phosphodiesterase 10A | 2ovy | 71.33 | | 4. |
42 | PDE1B | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Q01064 | PDE1B1 PDES1B | 4qj | Crystal structure of human PDE1B with inhibitor 3 | 5b25 | 79.33 | | 0.058 |
43 | PDE1B | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Q01064 | PDE1B1 PDES1B | 0nk | Crystal structure of human PDE1B bound to inhibitor 7A (6,7,8-trimethoxy-N-(pentan-3-yl)quinazolin-4-amine) | 4npv | 83.47 | | 35. |
44 | PDE1B | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Q01064 | PDE1B1 PDES1B | 0ny | PDE1b complexed with compound 3S | 5w6e | 90.26 | | no data |
45 | PDE1B | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Q01064 | PDE1B1 PDES1B | 0ny | Crystal structure of human PDE1B bound to inhibitor 19A (7,8-dimethoxy-N-[(2S)-1-(3-methyl-1H-pyrazol-5-yl)propan-2-yl]quinazolin-4-amine) | 4npw | 90.63 | | no data |
46 | PDE1B | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Q01064 | PDE1B1 PDES1B | 8hm | Crystal structure of human PDE1B catalytic domain in complex with inhibitor 16j (6-(4-Methoxybenzyl)-9-((tetrahydro-2H-pyran-4-yl)methyl)-8,9,10,11-tetrahydropyrido[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one) | 5uoy | 82.89 | | 27. |
47 | PDE1B | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Q01064 | PDE1B1 PDES1B | 8hp | Crystal structure of human PDE1B catalytic domain in complex with inhibitor 3 (6-(4-chlorobenzyl)-8,9,10,11-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one) | 5up0 | 80.09 | | 460. |
48 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | epv | Crystal structure of human phosphodiesterase 2A with 1-(5-tert-butoxy-2-chloro-phenyl)-N-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7j | 79.74 | | no data |
49 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | eoy | Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chloro-5-isobutoxy-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7g | 77.65 | | no data |
50 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | eoj | Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chlorophenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7d | 76.22 | | no data |
51 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | dy1 | PDE2 complexed with 2-[6-fluoro-8-methylsulfonyl-9-[(1R)-1-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid | 6blf | 84.13 | | no data |
52 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7ov | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluoro-3-iodophenyl)carbonyl]-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5u00 | 82.69 | | 2. |
53 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | ibm | hPDE2A catalytic domain complexed with IBMX | 3itu | 85.32 | | 40000. |
54 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | q2t | PDE2a catalytic domain in complex with a brain penetrant inhibitor | 4d08 | 85.64 | | 10. |
55 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 788 | PDE2a catalytic domain in complex with a brain penetrant inhibitor | 4d09 | 77.3 | | 1.7 |
56 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 1l6 | Crystal structure of of PDE2-inhibitor complex | 4jib | 77.24 | | 45. |
57 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7om | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX with [1,2,4]triazolo[1,5-a]pyrimidin-7-yl}-N-(naphthalene-2-yl)piperidine-3-carboxamide | 5tz3 | 80.89 | | 140. |
58 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7og | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 3-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl-1-[(naphthalene-2-yl)carbonyl]piperidine | 5tza | 81.51 | | 1. |
59 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7oj | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzz | 82.37 | | 14. |
60 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7oj | Crystal Structure of human PDE2a in complex with (5S)-1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzc | 82.24 | | 8. |
61 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7op | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluorophenyl)carbonyl]-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzh | 80.38 | | 679. |
62 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7p4 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3,4-difluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzw | 80.33 | | 987. |
63 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7oy | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-chloro-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzx | 82.38 | | 52. |
64 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 19f | Crystal structure of PDE2 catalytic domain in complex with BAY60-7550 | 4htx | 85.3 | | 4.7 |
65 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 19f | PDE2 catalytic domain complexed with inhibitors | 5u7d | 84.39 | | 0.5 |
66 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7xs | PDE2 catalytic domain complexed with inhibitors | 5u7i | 77.23 | | 66.6 |
67 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7xv | PDE2 catalytic domain complexed with inhibitors | 5u7j | 76.49 | | 389.6 |
68 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7y1 | PDE2 catalytic domain complexed with inhibitors | 5u7k | 87.83 | | 7.1 |
69 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 7y4 | PDE2 catalytic domain complexed with inhibitors | 5u7l | 84.82 | | 423. |
70 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 9gj | Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders | 5vp0 | 87.81 | | 0.61 |
71 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 9ga | Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders | 5vp1 | 84.3 | | 0.51 |
72 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | 87r | Crystal structure of human phosphodiesterase 2A in complex with 6-methyl-N-(1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide | 5xkm | 90.77 | | 24. |
73 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | czv | Crystal Structure of PDE2 in complex with compound 16 | 6b96 | 87.76 | | 14.3 |
74 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | czy | Crystal structure of PDE2 in complex with complex 9 | 6b97 | 89.48 | | 237. |
75 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | eog | Crystal structure of human phosphodiesterase 2A with 1-(2-chlorophenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7e | 79.99 | | no data |
76 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | eos | Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-isobutoxy-phenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7f | 83.6 | | no data |
77 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | ep7 | Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-methoxy-phenyl)-N-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7i | 77.68 | | no data |
78 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | fkv | PDE2 in complex with compound 7 | 6cyb | 98.71 | | no data |
79 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | fkj | PDE2 in complex with compound 5 | 6cyc | 98.36 | | no data |
80 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | fkg | PDE2 in complex with compound 7 | 6cyd | 97.33 | | no data |
81 | PDE2A | cGMP-dependent 3',5'-cyclic phosphodiesterase | O00408 | | c6z | PDE2 in complex with molecule 5 | 6ezf | 92.06 | | no data |
82 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13370 | | 666 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B In COMPLEX WITH A DIHYDROPYRIDAZINE INHIBITOR | 1so2 | 79.84 | | 0.27 |
83 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13370 | | ibm | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH IBMX | 1soj | 86.37 | | 242. |
84 | PDE4A | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | P27815 | DPDE2 | 0mo | Crystal structure of human PDE4a with 4-(3-butoxy-4-methoxyphenyl)methyl-2-imidazolidone | 3i8v | 88.89 | | no data |
85 | PDE4A | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | P27815 | DPDE2 | pnx | The structure of PDE4A with pentoxifylline at 2.84A resolution | 3tvx | 82.51 | | 72000. |
86 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | zg2 | Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine inhibitor | 3o57 | 78.29 | | 0.0794 |
87 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | via | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Sildenafil | 1xos | 85.67 | | 20000. |
88 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | vdn | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Vardenafil | 1xot | 76.23 | | 3800. |
89 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | 6m5 | Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor NPD-001 | 5laq | 73.98 | | no data |
90 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | 19t | Selective Inhibition of the Catalytic Domain Of Human Phosphodiesterase 4B With A-33 | 4myq | 91.43 | | 32. |
91 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | 066 | Catalytic domain of human phosphodiesterase 4B2B in complex with a quinoline inhibitor | 3gwt | 84.08 | | 0.00794 |
92 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | rol | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R,S)-Rolipram | 1xn0 | 92.47 | | 570. |
93 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | rol | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Rolipram | 1xmy | 87.97 | | 50.12 |
94 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | rol | Crystal structure of PDE4B2B complexed with Rolipram (R & S) | 1ro6 | 89.41 | | 350. |
95 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | fil | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Filaminast | 1xlz | 83.2 | | 960. |
96 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | pil | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Piclamilast | 1xm4 | 89.89 | | 0.041 |
97 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | rof | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Roflumilast | 1xmu | 89.15 | | 0.84 |
98 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | cio | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Cilomilast | 1xlx | 89.04 | | 25. |
99 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | 20a | Crystal structure of PDE4B catalytic domain in complex with a pyrazolopyridine inhibitor | 3d3p | 82.07 | | 3.16 |
100 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | sk4 | Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor | 3frg | 84.81 | | 3.98 |
101 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | 0cp | Crystal structure of human PDE4b with 5-[3-[(1S,2S,4R)-Bicyclo[2.2.1]hept-2-yloxy]-4-methoxyp henyl]tetrahydro-2(1H)-pyrimidinone reveals ordering of the C-terminal helix residues 502-509. | 3kkt | 93.74 | | no data |
102 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | z72 | Catalytic Domain of Human Phosphodiesterase 4B in Complex with A Coumarin-Based Inhibitor | 3ly2 | 87.74 | | 5. |
103 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | nvw | Crystal structure of phosphodiesterase 4B in complex with compound 31e | 3w5e | 90.91 | | 11. |
104 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | qpc | Crystal structure of phosphodiesterase 4B in complex with compound 10f | 3wd9 | 91.37 | | 8.3 |
105 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | 2o5 | PDE4 catalytic domain | 4nw7 | 90.19 | | 237. |
106 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | 6qq | Human Phospodiesterase 4B in complex with pyridyloxy-benzoxaborole based inhibitor | 5k6j | 86.66 | | no data |
107 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Q07343 | DPDE4 | hbt | Catalytic domain of human phosphodiesterase 4B2B in complex with a tetrahydrobenzothiophene inhibitor | 3hmv | 91.86 | | 50.12 |
108 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | m99 | Crystal structure of PDE4D2 in complex with inhibitor L-869299 | 2fm5 | 77.54 | | 43. |
109 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | m98 | Crystal structure of PDE4D in complex with L-869298 | 2fm0 | 77.96 | | 0.4 |
110 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | krd | Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-48 | 6njh | 92.77 | | no data |
111 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | kr4 | Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-49 | 6nji | 93.77 | | no data |
112 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | ihm | Crystal structure of the catalytic domain of PDE4D2 with (S)-N-(3-{1-[1-(3-Cyclopropylmethoxy-4-difluoromethoxyphenyl)-2-(1-oxypyridin-4-yl)-ethyl]-1H-pyrazl-3-yl}phenyl)acetamide | 3v9b | 83.43 | | 0.5 |
113 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | ffz | Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1335 | 6hwo | 78.64 | | no data |
114 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | e8h | Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-007 | 6fw3 | 77.25 | | no data |
115 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | e6z | Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-048 | 6ftw | 82.49 | | no data |
116 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | d62 | Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356 | 6fe7 | 78.26 | | no data |
117 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | d5z | Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1086 | 6feb | 76.94 | | no data |
118 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | d5t | Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-226 | 6fdi | 75.88 | | no data |
119 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | aku | Crystal structure of PDE4D complexed with a novel inhibitor | 6inm | 75.62 | | no data |
120 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | aku | Crystal structure of PDE4D complexed with a novel inhibitor | 6ink | 74.64 | | no data |
121 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | ako | Crystal structure of PDE4D complexed with a novel inhibitor | 6ind | 75.94 | | no data |
122 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | ak0 | Crystal structure of PDE4D complexed with a novel inhibitor | 6imt | 77.73 | | no data |
123 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | ajx | Crystal structure of PDE4D complexed with a novel inhibitor | 6imr | 86.81 | | no data |
124 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | ajl | Crystal structure of PDE4D complexed with a novel inhibitor | 6imo | 78.19 | | no data |
125 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | 6m5 | Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-001 | 5lbo | 74.8 | | no data |
126 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | rol | Crystal structure of human phosphodiesterase 4d with rolipram | 3g4k | 91.53 | | 288. |
127 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | rol | Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Rolipram | 1tbb | 88.36 | | no data |
128 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | rol | Crystal structure of PDE4D2 in complex with (R,S)-rolipram | 1oyn | 84.82 | | 550. |
129 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | rol | Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity | 1q9m | 85.88 | | 330. |
130 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | pil | Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Piclamilast | 1xon | 94.23 | | 0.021 |
131 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | rof | Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Roflumilast | 1xoq | 88.96 | | 0.68 |
132 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | rof | Crystal structure of human phosphodiesterase 4d with roflumilast | 3g4l | 88.67 | | 5.8 |
133 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | cio | Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Cilomilast | 1xom | 87.01 | | 11. |
134 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | ev1 | Crystal structure of human phosphodiesterase 4d (PDE4d) with papaverine. | 3iak | 78.67 | | no data |
135 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | d71 | Crystal structure of human phosphodiesterase 4d with d155871 | 3g4i | 82.99 | | 0.91 |
136 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | 15x | Crystal structure of human phosphodiesterase 4D with bound allosteric modulator | 3iad | 89.44 | | 1. |
137 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | ibm | Structure of PDE4D2-IBMX | 1zkn | 75.57 | | 31000. |
138 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | 0mo | The structure of the catalytic domain of human PDE4d with 4-(3-Butoxy-4-methoxyphenyl)methyl-2-imidazolidone | 3k4s | 86.23 | | no data |
139 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | j25 | Crystal structure of the catalytic domain of PDE4D2 complexed with compound 10d | 3sl5 | 77.23 | | 22. |
140 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | 3gj | PDE4D complexed with inhibitor | 4w1o | 83.64 | | no data |
141 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | 3kq | PDE4 complexed with inhibitor | 4wcu | 88.8 | | 3. |
142 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | 6pt | PDE4 crystal structure in complex with small molecule inhibitor | 5k1i | 83.26 | | 9.2 |
143 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | 6q2 | PDE4D crystal structure in complex with small molecule inhibitor | 5k32 | 92.05 | | no data |
144 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | 7dj | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH A TETRAFLUORANLINE COMPOUND | 5tkb | 78.37 | | 13. |
145 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | r91 | Crystal structure of the PDE4D2 catalytic domain in complex with inhibitor (R)-Zl-n-91 | 5wh5 | 89.98 | | no data |
146 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | akj | Crystal structure of PDE4D2 in complex with inhibitor (S_Zl-n-91) | 5wh6 | 89.95 | | no data |
147 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | e31 | Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004 | 6boj | 92.79 | | no data |
148 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | cv8 | Crystal structure of the PDE4D catalytic domain in complex with GEBR-7b | 6f6u | 82.35 | | no data |
149 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | czk | Crystal structure of the PDE4D catalytic domain in complex with GEBR-54 | 6f8r | 81.79 | | no data |
150 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | czt | Crystal structure of the PDE4D catalytic domain in complex with GEBR-4a | 6f8t | 80.33 | | no data |
151 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | czq | Crystal structure of the PDE4D catalytic domain in complex with GEBR-20b | 6f8u | 83.39 | | no data |
152 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | d0b | Crystal structure of the PDE4D catalytic domain in complex with GEBR-18b | 6f8v | 85.49 | | no data |
153 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | d0e | Crystal structure of the PDE4D catalytic domain in complex with GEBR-18a | 6f8w | 87.55 | | no data |
154 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | d08 | Crystal structure of the PDE4D catalytic domain in complex with GEBR-26g | 6f8x | 90.03 | | no data |
155 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | d5n | Crystal structure of the PDE4D catalytic domain in complex with GEBR-32a | 6fdc | 78.52 | | no data |
156 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | dd5 | Crystal structure of the PDE4D catalytic domain in complex with GEBR-32a | 6fdc | 79.27 | | no data |
157 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | jn7 | Crystal structure of the catalytic domain of PDE4D2 with compound 10o | 3sl8 | 72.45 | | 290. |
158 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | jn8 | Crystal structure of the catalytic domain of PDE4D2 with compound 12c | 3sl6 | 74.15 | | no data |
159 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Q08499 | DPDE3 | jn4 | Crystal structure of the catalytic domain of PDE4D2 with compound 10D | 3sl4 | 74.98 | | 27. |
160 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | via | Crystal structure of Human Phosphodiesterase 5 complexed with Sildenafil(Viagra) | 1udt | 80.38 | | 0.5 |
161 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | via | Crystal structure of PDE5 in complex with sildenafil | 2h42 | 86.91 | | 2.4 |
162 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | vdn | Crystal Structure of PDE5A1 catalytic domain in complex with Vardenafil | 3b2r | 82.34 | | no data |
163 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | vdn | Crystal structure of Human Phosphodiesterase 5 complexed with Vardenafil(Levitra) | 1uho | 75.34 | | 0.6 |
164 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 9t9 | Crystal structure of PDE5 in complex with inhibitor LW1805 | 6acb | 71.57 | | no data |
165 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 9m0 | Crystal structure of PDE5 in complex with inhibitor LW1634 | 5zz2 | 88.42 | | no data |
166 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 7ca | Crystal structure of PDE5A1 in complex with icarisid II | 2h44 | 98.11 | | 1700. |
167 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 5io | Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors | 4oew | 75.14 | | 152. |
168 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 5bb | Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors | 4ia0 | 70.85 | | 77. |
169 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 24e | Crystal structure of PDE5 in complex with inhibitor 5R | 4md6 | 86.33 | | 17. |
170 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | cia | Crystal structure of Human Phosphodiesterase 5 complexed with tadalafil(Cialis) | 1udu | 88.28 | | 0.9 |
171 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | wan | Crystal structure of the PDE5A catalytic domain in complex with a novel inhibitor | 3bjc | 76.78 | | 110. |
172 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | ibm | Crystal structure of PDE5A1-IBMX | 1rkp | 87.16 | | no data |
173 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 5fo | Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors | 3shy | 72.12 | | 90.9 |
174 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 5co | Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors | 3shz | 67.22 | | 35.9 |
175 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 5bo | Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors | 3sie | 77.36 | | 13.3 |
176 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | ni0 | Crystal structure of PDE5A in complex with its inhibitor | 4g2w | 71.47 | | 1.6 |
177 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 5ba | Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors | 4i9z | 74.49 | | 18.2 |
178 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | 5eo | Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors | 4oex | 69.65 | | 1450. |
179 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | O76074 | PDE5 | ni5 | Crystal structure of PDE5A complexed with its inhibitor | 4g2y | 70.06 | | 1000. |
180 | PDE7A | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | Q13946 | | ibm | Multiple Determinants for Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases | 1zkl | 82.71 | | 8100. |
181 | PDE7A | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | Q13946 | | 32v | PDE7A catalytic domain in complex with 2-(Cyclopentylamino)thieno[3,2-d]pyrimidin-4(3H)-one derivative | 4pm0 | 86.36 | | 45. |
182 | PDE7A | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | Q13946 | | epk | Co-crystal structure of 3-ethyl-2-(isopropylamino)-7-(pyridin-3-yl)thieno[3,2-d]pyrimidin-4(3H)-one bound to PDE7A | 4y2b | 81.24 | | 4.4 |
183 | PDE7A | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | Q13946 | | tc8 | PDE7A catalytic domain in complex with 3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one | 3g3n | 76.02 | | 510. |
184 | PDE8A | High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | O60658 | | ibm | Crystal structure of PDE8A catalytic domain in complex with IBMX | 3ecn | 79.29 | | 698000. |
185 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | 9q9 | Crystal structure of the PDE9 catalytic domain in complex with inhibitor 2 | 6a3n | 79.66 | | no data |
186 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | wtc | Human phosphodiesterase 9 in complex with inhibitor | 3jsi | 87.55 | | 2.1 |
187 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | jar | Human PDE9 in complex with selective inhibitor | 3jsw | 78.58 | | 66. |
188 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | ibm | Crystal structure of PDE9 in complex with IBMX | 2hd1 | 80.87 | | 500000. |
189 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | ibm | Crystal structure of PDE9A (E406A) mutant in complex with IBMX | 3n3z | 86.78 | | no data |
190 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | ibm | Crystal structure of PDE9A(Q453E) in complex with IBMX | 3qi4 | 78.45 | | 117200. |
191 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | ibm | human phosphodiestrase 9 (inhibited by omitting divalent cation) in complex with cGMP | 3dyq | 69.95 | | no data |
192 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | ibm | human phosphodiestrase-5'GMP complex (EP), produced by soaking with 20mM cGMP+20 mM MnCl2+20 mM MgCl2 for 2 hours, and flash-cooled to liquid nitrogen temperature when substrate was still abudant. | 3dys | 74.07 | | no data |
193 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | pdb | Crystal structure of PDE9A(Q453E) in complex with inhibitor BAY73-6691 | 3qi3 | 84.55 | | 164200. |
194 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | pdb | Crystal structure of the PDE9A catalytic domain in complex with (R)-BAY73-6691 | 3k3e | 84.52 | | 22. |
195 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | bye | Crystal structure of the PDE9A catalytic domain in complex with (S)-BAY73-6691 | 3k3h | 83.57 | | 88. |
196 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | 7rg | Human phosphodiesterase 9 in complex with inhibitors | 4e90 | 74.2 | | no data |
197 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | 0wf | Human pde9 in complex with selective compound | 4g2j | 76.14 | | 11. |
198 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | 0wl | Human PDE9 in complex with selective compound | 4g2l | 73.69 | | 32. |
199 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | luo | Crystal structure of the PDE9A catalytic domain in complex with inhibitor 28 | 4gh6 | 72.22 | | 21. |
200 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | 35o | phosphodiesterase-9A in complex with inhibitor WYQ-C36D | 4qge | 76.56 | | 0.5 |
201 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | 49e | Crystal structure of PDE9 in complex with racemic inhibitor C33 | 4y86 | 77.62 | | no data |
202 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | 49d | Crystal structure of PDE9 in complex with racemic inhibitor C33 | 4y86 | 85.54 | | no data |
203 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | 49d | Crystal structure of phosphodiesterase 9 in complex with (S)-C33 | 4y8c | 86.94 | | 11. |
204 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | O76083 | | ibm | Crystal structure of the human Phosphodiesterase 9A catalytic domain complexed with IBMX | 2yy2 | 75.07 | | no data |